Exploring Pharmacogenomics in Memory Care 

February 9, 2026

 

Tuesday, May 12 at 1:00 pm ET

Presented by:

Caroline Garvey, PharmD, BCGP, Director of Clinical Operations, PharMerica
Matthew J Palmer, PharmD, BCGP, Senior Director of Clinical Operations, PharMerica 

 

This session explores the emerging role of pharmacogenomics (PGx) in memory care, highlighting how genetic insights can inform more personalized and effective medication management. Attendees will gain a foundational understanding of PGx concepts and terminology, review the evolving financial and regulatory landscape, and identify practical criteria for implementing PGx testing in long-term and memory care
settings. Real-world scenarios will illustrate how PGx can be leveraged to optimize therapy, reduce adverse drug events, and enhance outcomes for residents with cognitive impairment.

 

Learning Objectives:
1. Define the fundamental principles and key terminology of pharmacogenomics (PGx)
2. Evaluate the current financial, reimbursement, and regulatory landscape impacting PGx testing
3. Identify appropriate patient selection criteria and use cases for PGx testing in long-term and memory care settings
4. Apply pharmacogenomic insights to optimize medication management through case-based scenarios

 

Register Now

 

This program has been approved for one hour of nursing continuing education, as well as by NAB/NCERS for nursing home administrators (approval #20270511-1-A120666-DL), and by NABP for pharmacists. Provider (Pedagogy, Inc) approved by the California Board of Registered Nursing, Provider #: CEP 15467 for 1.00 Contact Hours. Attendees must be in attendance for at least 50 minutes to receive credit.